Ivan Pedrosa, M.D., Ph.D.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    Health Tech International
    Topic:
    Telemedicine
    Date added:
    12/07/2021
    Date updated:
    05/01/2024
    Relationship end date:
    12/31/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merck
    Topic:
    Advisory board
    Date added:
    12/07/2021
    Date updated:
    05/01/2024
    Relationship end date:
    03/04/2021
Return to 156 Renal Cell Carcinoma Multimodality Conference: (040422)